Shares of the California-based life sciences company focused on the research, development, and commercialization of Cannabis products Juva Life Inc (OTCQB: JUVAF) closed up 34.47 percent on Thursday at $0.4751.
A day range of $0.4900 to $0.3660 was seen by Juva stock on the day. In the absence of actual news, JUVAF stock was upbeat. Recent developments, however, might shed light on the JUVAF.
What has recently happened at JUVAF?
In order to make cannabis more investment grade, Juva is developing the sector’s next-generation business model. To identify molecular profiles for unmet medical needs, JUVAF employs state-of-the-art tools in discovery, development, and data science, including in-house research, cultivation, manufacturing, retailing, and delivery services. The JUVAF platform is primarily being used in cannabis-related applications, including consumer and pharma applications.
An underutilized physical asset was recently sold by Juva for a net sum of $1.1 million (USD).
- As part of its product development program, JUVAF provided a glimpse at its Stockton, California cannabis farm.
- According to a press release dated November 25, 2020, Juva identified its two assets in Stockton as the Navy Drive and San Juan campuses.
- San Juan is progressing rapidly; subsequently, JUVAF determined that its 11,500 sq. ft. Navy Drive facility was non-essential and decided to sell it.
How did JUVAF proceed?
It was the indirect wholly-owned subsidiary of JUVAF, VG Enterprises, LLC, which successfully completed a purchase agreement encompassing the facility and all permits. A net purchase price of $1.1 million (USD) is set forth in the agreement, with the proceeds to be used by Juva (JUVAF) for business development.